Pandora names Berta de Pablos-Barbier as next CEO as Lacik to retire

Investing.comTuesday, September 30, 2025 at 6:27:07 AM
Pandora names Berta de Pablos-Barbier as next CEO as Lacik to retire
Pandora has announced the appointment of Berta de Pablos-Barbier as its new CEO, succeeding the retiring Lacik. This leadership change is significant as it marks a new chapter for the company, which is known for its innovative jewelry designs. Berta's experience and vision are expected to drive Pandora's growth and adapt to the evolving market, making this transition an exciting development for both the brand and its customers.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Pandora CEO to retire in 2026, replaced by marketing chief
NeutralFinancial Markets
Pandora's CEO has announced plans to retire in 2026, with the company's marketing chief set to take over the role. This transition is significant as it marks a new chapter for the company, potentially bringing fresh ideas and strategies to the forefront. As the music streaming industry continues to evolve, leadership changes like this can impact the company's direction and performance.
Pandora CEO Lacik to retire in March 2026; De PablosBarbier to succeed
NeutralFinancial Markets
Pandora's CEO, Alexander Lacik, has announced his retirement, effective March 2026, with De PablosBarbier set to take over the leadership role. This transition marks a significant moment for the company as it prepares for new strategic directions under fresh leadership. The change is important not only for Pandora's internal dynamics but also for its stakeholders, who will be watching closely to see how the new CEO will steer the brand in a competitive market.
Latest from Financial Markets
How AI Helps a Logistics Giant Thrive During a Downturn
PositiveFinancial Markets
C.H. Robinson's CEO highlights how automation and artificial intelligence are driving the company's success, even amidst a revenue decline. This is significant as it showcases the potential of technology to enhance efficiency and profitability in challenging economic times, setting a precedent for other companies in the logistics sector.
Understanding Index Funds vs. ETFs for Americans
NeutralFinancial Markets
This article explores the differences between index funds and ETFs, two popular investment options for Americans. Understanding these differences is crucial for investors looking to optimize their portfolios and make informed financial decisions. With the rise of passive investing, knowing which option suits your financial goals can significantly impact your investment strategy.
What Is the True Lifetime Cost of Owning a Home?
NeutralFinancial Markets
Understanding the true lifetime cost of owning a home is crucial for potential buyers. This article delves into various expenses beyond the mortgage, such as maintenance, taxes, and insurance, which can significantly impact financial planning. By shedding light on these hidden costs, it empowers readers to make informed decisions about homeownership, ensuring they are prepared for the long-term financial commitment involved.
Ranking the Top 10 Richest Film Producers of All Time
PositiveFinancial Markets
The latest ranking of the top 10 richest film producers highlights the immense wealth and influence of key figures in the film industry. With names like George Lucas and Steven Spielberg leading the pack, this list not only showcases their financial success but also underscores their significant contributions to cinema. Understanding who these producers are and how they amassed their fortunes can provide insights into the evolving landscape of film production and the business strategies that drive it.
Bloomin' Brands executive vice president W. Michael Healy to depart in October
NeutralFinancial Markets
W. Michael Healy, the executive vice president of Bloomin' Brands, is set to leave the company in October. His departure marks a significant change for the organization, which operates several well-known restaurant chains. This transition could impact the company's strategic direction and leadership dynamics, making it a noteworthy development for stakeholders and industry observers.
KeyBanc highlights supportive policy signals for cell and gene therapy stocks
PositiveFinancial Markets
KeyBanc has recently pointed out encouraging policy signals that could benefit cell and gene therapy stocks. This is significant because supportive regulations can lead to increased investment and innovation in these fields, potentially improving patient outcomes and advancing medical science.